Results of a global research project, led by Eva Pressman, M.D., and Tim Dye, Ph.D., with the University of Rochester Medical Center (URMC), indicate that trust in science is the most powerful determinant of whether a person ...
Jan 13, 2022
0
37
Harnessing the power of genomics to find risk factors for major diseases or search for relatives relies on the costly and time-consuming ability to analyze huge numbers of genomes. A team co-led by a Johns Hopkins University ...
Jan 12, 2022
0
55
In a first-of-its-kind study comparing hundreds of millions of social media posts about online health topics, a team of researchers found that posts about COVID-19 were less likely to contain misinformation than posts about ...
Jan 12, 2022
4
218
Researchers at the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) developed an acoustic virtual reality-based archery game, enabling blind people to experience for the first time this type of technology, ...
Jan 04, 2022
0
35
Hundreds of thousands more people were confined to their homes in northern China Tuesday as the country battled its worst COVID surge in 21 months and locked-down residents took to social media to complain about food shortages.
Dec 28, 2021
0
4
(HealthDay)—A new program to boost the supply of cancer medicines for children in low- and middle-income countries has been announced by the World Health Organization (WHO) and St. Jude Children's Research Hospital.
Dec 22, 2021
0
6
(HealthDay)—Think what happens online stays online? Think again.
Dec 21, 2021
0
7
Two researchers at Ruhr-Universität Bochum (RUB) have come up with a new theory of consciousness. They have long been exploring the nature of consciousness, the question of how and where the brain generates consciousness, ...
Dec 20, 2021
7
1134
The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.
Dec 20, 2021
0
3
The EU's drug regulator will decide Monday whether to approve a COVID jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Dec 20, 2021
0
2
